SKEMPI 2.0: an updated benchmark of changes in protein–protein binding energy, kinetics and thermodynamics upon mutation
Open accessPublished version of a preprint
The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.
Abstract
We present SKEMPI 2.0, a major update to our database of binding free energy changes upon mutation for structurally resolved protein-protein interactions. This version now contains manually curated binding data for 7085 mutations, an increase of 133%, including changes in kinetics for 1844 mutations, enthalpy and entropy changes for 443 mutations, and 440 mutations which abolish detectable binding.
Overview
CoChat Summary
## TL;DR
SKEMPI 2.0 is an updated manually curated benchmark of mutation effects on structurally resolved protein–protein interactions, expanding the database to 7085 mutations and adding kinetics, thermodynamics, and non-binding cases. The dataset is broad but strongly biased toward certain interaction classes and well-studied systems, and the paper provides annotations useful for analyzing homology and mutant cycles.
## Key findings
- The database contains 7085 mutations, a 133% increase over the previous version.
- It includes 1844 mutations with kinetics changes, 443 with enthalpy and entropy changes, and 440 mutations that abolish detectable binding.
- The entries span 295 publications and include 610 double mutant cycles, 218 additional double mutant cycles in a third-mutation background, 45 triple mutant cubes, and 14 fourth-order interaction examples.
- Reported ranges include ΔΔG from –12.4 to 12.4 kcal/mol, Δlog10(kon) from –3.6 to 2.4, Δlog10(koff) from –6.0 to 6.8, ΔΔH from –18.3 to 26.5 kcal/mol, and ΔΔS from –61 to 80 cal/mol·K.
## Methods
- Manual literature curation of structurally resolved protein–protein interaction mutations, with stringent checks to match the structure and affinity paper to the same protein, species, cofactors, chains, and post-translational modifications.
- Data were collected from prior SKEMPI entries and new literature searches; the paper states that just over two fifths of the data come from the previous SKEMPI version, and new data were supplemented from sources including ABbind, PROXiMATE, and dbMPIKT.
- Entries were annotated with wild-type and mutant affinities, kinetic and thermodynamic parameters when available, experimental method, residue location, homologous interactions, and cleaned PDB files; the paper also describes calculations from reported values when needed.
## Limitations
- The paper states that the database is biased toward the interests and capabilities of the research community, with over-representation of certain interaction classes and organisms.
- It also notes a structural selection bias: only interactions with structures are included, so there is no representation of “fuzzy” complexes; this is stated in the paper.
- Evident from the text: many error comparisons rely on pairs from different groups or techniques, and the paper notes that some entries near detection limits have large errors, especially very destabilizing mutations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
0 Valid · 0 Not valid · 1 Not checked · 74 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“The largest contribution comes from the group of the late Michael Laskowski Jr., a systematic study of all possible mutations at selected sites in the turkey ovomucoid third domain and its inhibitory interactions with four proteases (Lu et al., 2001), as well as studies of interactions of the same domain in other bird species and the design of ultra-high affinity broad-spectrum inhibitors.”
§ SKEMPI 2.0: an updated benchmark of changes in protein–protein binding energy, kinetics and thermodynamics upon mutation > 3 Results and discussion > 3.2 Notable studies comprising SKEMPI 2.0 The investigations from which SKEMPI data is derived are diverse, spanning many biological processes and reported in 295 publications including systematic scans, alanine and homolog scanning, design studies including computational design and designs derived from phage display, double mutant cycle studies, antibody engineering, biologic drug design and the evaluation of pathological mutations. The largest contribution comes from the group of the late Michael Laskowski Jr., a systematic study of all possible mutations at selected sites in the turkey ovomucoid third domain and its inhibitory interactions with four proteases (Lu et al., 2001), as well as studies of interactions of the same domain in other bird species and the design of ultra-high affinity broad-spectrum inhibitors. Substantial data also come from investigations into the inhibitory interactions of class A β-lactamases from the groups of Gideon Schreiber (e.g. Reichmann et al., 2007) and Timothy Palzkill (e.g. Brown et al., 2013), as well as cytokine receptor interactions, in particular studies of type I interferons also from the Schreiber group (e.g. Roisman et al., 2001) and that of K. Christopher Garcia (Thomas et al., 2011), but also the study of the GM-CSF/GMRα interaction from the group of Michael W. Parker (Broughton et al., 2016). Other prominent sources of data are studies into hormone receptor interactions, in particular the human growth hormone receptor from the group of Jim Wells (e.g. Cunningham and Wells, 1991) and the prolactin receptor from the group of Michael E. Hodsdon (Kulkarni et al., 2010), as well as studies into antigen recognition including the combined computational and experimental design study to enhance affinity of the AQC2 antibody to integrin α-1 from the group of Herman Van Vlijmen (Clark et al., 2006), the dissection of the interactions of broadly neutralizing antibodies targeting HIV gp120 (Clark et al., 2017) from the group of Richard A. Friesner, and various investigations from the group of Roy A. Mariuzza (e.g. Dall'Acqua et al., 1998). Also notable is the alanine scanning of the urokinase-type plasminogen activator and its receptor from the group of Michael Ploug (Gardsvoll et al., 2006), studies of Ras effector interactions from the group of Christian Herrmann (e.g. Kiel et al., 2004), investigations of pMHC/TCR interactions from the group of Brian Baker (e.g. Piepenbrink et al., 2013), and investigations into the cognate and non-cognate recognition of Escherichia coli colicin DNase bacteriotoxins by their immunity proteins from the group of Colin Kleanthous (e.g. Li et al., 1997).
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For 84% of 1741 such pairs, both entries give a ΔΔG value within 1 kcal.mol−1 of each other.”
§ SKEMPI 2.0: an updated benchmark of changes in protein–protein binding energy, kinetics and thermodynamics upon mutation > 3 Results and discussion > 3.3 Range and error Range: The changes in binding free energy upon mutation range from –12.4 to 12.4 kcal.mol−1, as in SKEMPI 1.1, with Δ log 10kon ranging from –3.6 to 2.4, Δ log 10koff ranging from –6.0 to 6.8, ΔΔH ranging from –18.3 to 26.5 kcal.mol−1, and ΔΔS ranging from –61 to 80 cal.mol−1.K−1. Around 60 mutants are very destabilizing, reducing binding energy by 8 kcal.mol−1 or more. These are all in enzyme/inhibitor complexes such as the inhibition of acetylcholinesterase by the snake venom fasciculin, or the inhibition of enzymes which would be detrimental should they unbind and become active in the wrong location, such as nucleases (barnase/barstar, colicin E9 DNase/Im9, RNase A/angiogenin) and proteases (such as trypsin/BPTI). These interactions tend to be around picomolar affinity and are at the upper limit of what can be detected, due to the time required to reach equilibrium and the low concentrations required by the mass action law to probe informative regions of the binding curve. These very destabilizing mutations reduce affinity into the micromolar range, near the lower limit of what can be quantified using standard methods. As a consequence of both mutant and wild-type affinities being near detection thresholds, errors in these entries are typically large. Further, while some mutations may cause changes in affinity larger than seven orders of magnitude, the absence of affinities for such mutations in the benchmark can be explained by the fact that such mutations would involve affinities beyond the upper or lower limit. Indeed, there are new entries in which single or double substitutions reduce binding from tens of picomolar to having no detectable binding. For many of the highly destabilizing mutations a crystal structure for the mutant has also been solved, and the 30 most stabilizing mutations in the database (ΔΔG ¡ –5 kcal.mol−1) consist of the reverse mutation applied to these structures. These are mostly single or double mutants, but include mutations to up to 27 residues of the non-cognate Colicin E2/Im9 complex, which move it toward the cognate E9/Im9 in sequence space (Li et al., 1997). Errors: Standard errors in KD are typically reported in the order of 50%, around 0.25 kcal.mol−1. These estimates are derived by repeat measurements using the same equipment, environment and protocol, and thus do not include errors arising from systematic bias. Such biases can, however, be estimated from pairs of entries in which the same mutation is evaluated by different groups or using different techniques. For 84% of 1741 such pairs, both entries give a ΔΔG value within 1 kcal.mol−1 of each other. For 704 pairs for which kon is available for both, 80% have Δ log 10(kon) within 0.5 of each other. For 702 pairs for which koff is available, 83% have Δ log 10(koff) within 0.5. For the 62 pair with both ΔΔH and ΔΔS values, 61% have ΔΔH within 3.0 kcal.mol−1 of each other and 58% have ΔΔS within 10 cal.mol−1.K−1 of each other.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For many of the highly destabilizing mutations a crystal structure for the mutant has also been solved, and the 30 most stabilizing mutations in the database (ΔΔG ¡ –5 kcal.mol−1) consist of the reverse mutation applied to these structures.”
§ SKEMPI 2.0: an updated benchmark of changes in protein–protein binding energy, kinetics and thermodynamics upon mutation > 3 Results and discussion > 3.3 Range and error Range: The changes in binding free energy upon mutation range from –12.4 to 12.4 kcal.mol−1, as in SKEMPI 1.1, with Δ log 10kon ranging from –3.6 to 2.4, Δ log 10koff ranging from –6.0 to 6.8, ΔΔH ranging from –18.3 to 26.5 kcal.mol−1, and ΔΔS ranging from –61 to 80 cal.mol−1.K−1. Around 60 mutants are very destabilizing, reducing binding energy by 8 kcal.mol−1 or more. These are all in enzyme/inhibitor complexes such as the inhibition of acetylcholinesterase by the snake venom fasciculin, or the inhibition of enzymes which would be detrimental should they unbind and become active in the wrong location, such as nucleases (barnase/barstar, colicin E9 DNase/Im9, RNase A/angiogenin) and proteases (such as trypsin/BPTI). These interactions tend to be around picomolar affinity and are at the upper limit of what can be detected, due to the time required to reach equilibrium and the low concentrations required by the mass action law to probe informative regions of the binding curve. These very destabilizing mutations reduce affinity into the micromolar range, near the lower limit of what can be quantified using standard methods. As a consequence of both mutant and wild-type affinities being near detection thresholds, errors in these entries are typically large. Further, while some mutations may cause changes in affinity larger than seven orders of magnitude, the absence of affinities for such mutations in the benchmark can be explained by the fact that such mutations would involve affinities beyond the upper or lower limit. Indeed, there are new entries in which single or double substitutions reduce binding from tens of picomolar to having no detectable binding. For many of the highly destabilizing mutations a crystal structure for the mutant has also been solved, and the 30 most stabilizing mutations in the database (ΔΔG ¡ –5 kcal.mol−1) consist of the reverse mutation applied to these structures. These are mostly single or double mutants, but include mutations to up to 27 residues of the non-cognate Colicin E2/Im9 complex, which move it toward the cognate E9/Im9 in sequence space (Li et al., 1997). Errors: Standard errors in KD are typically reported in the order of 50%, around 0.25 kcal.mol−1. These estimates are derived by repeat measurements using the same equipment, environment and protocol, and thus do not include errors arising from systematic bias. Such biases can, however, be estimated from pairs of entries in which the same mutation is evaluated by different groups or using different techniques. For 84% of 1741 such pairs, both entries give a ΔΔG value within 1 kcal.mol−1 of each other. For 704 pairs for which kon is available for both, 80% have Δ log 10(kon) within 0.5 of each other. For 702 pairs for which koff is available, 83% have Δ log 10(koff) within 0.5. For the 62 pair with both ΔΔH and ΔΔS values, 61% have ΔΔH within 3.0 kcal.mol−1 of each other and 58% have ΔΔS within 10 cal.mol−1.K−1 of each other.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For the 62 pair with both ΔΔH and ΔΔS values, 61% have ΔΔH within 3.0 kcal.mol−1 of each other and 58% have ΔΔS within 10 cal.mol−1.K−1 of each other.”
§ SKEMPI 2.0: an updated benchmark of changes in protein–protein binding energy, kinetics and thermodynamics upon mutation > 3 Results and discussion > 3.3 Range and error Range: The changes in binding free energy upon mutation range from –12.4 to 12.4 kcal.mol−1, as in SKEMPI 1.1, with Δ log 10kon ranging from –3.6 to 2.4, Δ log 10koff ranging from –6.0 to 6.8, ΔΔH ranging from –18.3 to 26.5 kcal.mol−1, and ΔΔS ranging from –61 to 80 cal.mol−1.K−1. Around 60 mutants are very destabilizing, reducing binding energy by 8 kcal.mol−1 or more. These are all in enzyme/inhibitor complexes such as the inhibition of acetylcholinesterase by the snake venom fasciculin, or the inhibition of enzymes which would be detrimental should they unbind and become active in the wrong location, such as nucleases (barnase/barstar, colicin E9 DNase/Im9, RNase A/angiogenin) and proteases (such as trypsin/BPTI). These interactions tend to be around picomolar affinity and are at the upper limit of what can be detected, due to the time required to reach equilibrium and the low concentrations required by the mass action law to probe informative regions of the binding curve. These very destabilizing mutations reduce affinity into the micromolar range, near the lower limit of what can be quantified using standard methods. As a consequence of both mutant and wild-type affinities being near detection thresholds, errors in these entries are typically large. Further, while some mutations may cause changes in affinity larger than seven orders of magnitude, the absence of affinities for such mutations in the benchmark can be explained by the fact that such mutations would involve affinities beyond the upper or lower limit. Indeed, there are new entries in which single or double substitutions reduce binding from tens of picomolar to having no detectable binding. For many of the highly destabilizing mutations a crystal structure for the mutant has also been solved, and the 30 most stabilizing mutations in the database (ΔΔG ¡ –5 kcal.mol−1) consist of the reverse mutation applied to these structures. These are mostly single or double mutants, but include mutations to up to 27 residues of the non-cognate Colicin E2/Im9 complex, which move it toward the cognate E9/Im9 in sequence space (Li et al., 1997). Errors: Standard errors in KD are typically reported in the order of 50%, around 0.25 kcal.mol−1. These estimates are derived by repeat measurements using the same equipment, environment and protocol, and thus do not include errors arising from systematic bias. Such biases can, however, be estimated from pairs of entries in which the same mutation is evaluated by different groups or using different techniques. For 84% of 1741 such pairs, both entries give a ΔΔG value within 1 kcal.mol−1 of each other. For 704 pairs for which kon is available for both, 80% have Δ log 10(kon) within 0.5 of each other. For 702 pairs for which koff is available, 83% have Δ log 10(koff) within 0.5. For the 62 pair with both ΔΔH and ΔΔS values, 61% have ΔΔH within 3.0 kcal.mol−1 of each other and 58% have ΔΔS within 10 cal.mol−1.K−1 of each other.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Standard errors in KD are typically reported in the order of 50%, around 0.25 kcal.mol−1.”
§ SKEMPI 2.0: an updated benchmark of changes in protein–protein binding energy, kinetics and thermodynamics upon mutation > 3 Results and discussion > 3.3 Range and error Range: The changes in binding free energy upon mutation range from –12.4 to 12.4 kcal.mol−1, as in SKEMPI 1.1, with Δ log 10kon ranging from –3.6 to 2.4, Δ log 10koff ranging from –6.0 to 6.8, ΔΔH ranging from –18.3 to 26.5 kcal.mol−1, and ΔΔS ranging from –61 to 80 cal.mol−1.K−1. Around 60 mutants are very destabilizing, reducing binding energy by 8 kcal.mol−1 or more. These are all in enzyme/inhibitor complexes such as the inhibition of acetylcholinesterase by the snake venom fasciculin, or the inhibition of enzymes which would be detrimental should they unbind and become active in the wrong location, such as nucleases (barnase/barstar, colicin E9 DNase/Im9, RNase A/angiogenin) and proteases (such as trypsin/BPTI). These interactions tend to be around picomolar affinity and are at the upper limit of what can be detected, due to the time required to reach equilibrium and the low concentrations required by the mass action law to probe informative regions of the binding curve. These very destabilizing mutations reduce affinity into the micromolar range, near the lower limit of what can be quantified using standard methods. As a consequence of both mutant and wild-type affinities being near detection thresholds, errors in these entries are typically large. Further, while some mutations may cause changes in affinity larger than seven orders of magnitude, the absence of affinities for such mutations in the benchmark can be explained by the fact that such mutations would involve affinities beyond the upper or lower limit. Indeed, there are new entries in which single or double substitutions reduce binding from tens of picomolar to having no detectable binding. For many of the highly destabilizing mutations a crystal structure for the mutant has also been solved, and the 30 most stabilizing mutations in the database (ΔΔG ¡ –5 kcal.mol−1) consist of the reverse mutation applied to these structures. These are mostly single or double mutants, but include mutations to up to 27 residues of the non-cognate Colicin E2/Im9 complex, which move it toward the cognate E9/Im9 in sequence space (Li et al., 1997). Errors: Standard errors in KD are typically reported in the order of 50%, around 0.25 kcal.mol−1. These estimates are derived by repeat measurements using the same equipment, environment and protocol, and thus do not include errors arising from systematic bias. Such biases can, however, be estimated from pairs of entries in which the same mutation is evaluated by different groups or using different techniques. For 84% of 1741 such pairs, both entries give a ΔΔG value within 1 kcal.mol−1 of each other. For 704 pairs for which kon is available for both, 80% have Δ log 10(kon) within 0.5 of each other. For 702 pairs for which koff is available, 83% have Δ log 10(koff) within 0.5. For the 62 pair with both ΔΔH and ΔΔS values, 61% have ΔΔH within 3.0 kcal.mol−1 of each other and 58% have ΔΔS within 10 cal.mol−1.K−1 of each other.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 75 claims and every source verdict.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additional dedicated datasets summarize curated information about properties and structure of antibodies.These databases include the structural database of kinetics and energetics of mutant protein interactions (SKEMPI) [17], and the antibody binding mutational database (AB-Bind) [18].”
From Computational and artificial intelligence-based methods for antibody development (2023) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“This dataset contains 7,085 entries, including single- and multi-point mutations.”
From A topology-based network tree for the prediction of protein–protein binding affinity changes following mutation (2020) · cites this paper as [39]
In the citing paper
“This model was evaluated by split-by-complex fivefold cross-validation over the Structural Kinetic and Energetic database of Mutant Protein Interactions (SKEMPI) V2.0 dataset (38).”
From Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization (2022) · cites this paper as [38]
In the citing paper
“The training and validation datasets were constructed from the SKEMPI V2.0 dataset (38), the largest antibody–antigen binding affinity dataset, which contains 342 complexes and 5,318 mutations in total.”
From Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization (2022) · cites this paper as [38]
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196 · cited 2×
“Processed PDB files: The PDB files for the interactions, as downloaded from the Protein Data Bank [8], often contain multiple copies of the interacting proteins in the unit cell or other chains irrelevant to the interaction.”
MethodOverview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353 · cited 10×
“, 289, 5528–5533. Kastritis,P.L. et al. (2011) A structure-based benchmark for protein-protein”
BackgroundInfluentialmCSM: Predicting the effects of mutations in proteins using graph-based signatures
Pires, D. E. V., Ascher, D. B., & Blundell, T. L. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt691 · Cited by 1,066
Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin
Fleishman, S. J., Whitehead, T. A., Ekiert, D. C., Dreyfus, C., Corn, J. E., Strauch, E.-M., Wilson, I. A., & Baker, D. (2011) · Science · doi:10.1126/science.1202617 · Cited by 585
Vreven, T., Moal, I. H., Vangone, A., Pierce, B. G., Kastritis, P. L., Torchala, M., Chaleil, R., Jiménez-García, B., Bates, P. A., Fernandez-Recio, J., et al. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.07.016 · Cited by 424
Self-citationThorn, K. S., & Bogan, A. A. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.3.284 · Cited by 403 · cited 3×
“1 were found by checking the references in the ASEdb [71] and PINT [36] databases,”
MethodInfluentialStructural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
Thomas, C., Moraga, I., Levin, D., Krutzik, P. O., Podoplelova, Y., Trejo, A., Lee, C., Yarden, G., Vleck, S. E., Glenn, J. S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.048 · Cited by 356
Plattner, N., Doerr, S., De Fabritiis, G., & Noé, F. (2017) · Nature Chemistry · doi:10.1038/nchem.2785 · Cited by 345
BeAtMuSiC: prediction of changes in protein–protein binding affinity on mutations
Dehouck, Y., Kwasigroch, J. M., Rooman, M., & Gilis, D. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt450 · Cited by 338
Strategy for analysing the co-operativity of intramolecular interactions in peptides and proteins
Horovitz, A., & Fersht, A. R. (1990) · Journal of Molecular Biology · doi:10.1016/0022-2836(90)90275-q · Cited by 335 · cited 2×
“Higher order interaction terms can be garnered from higher cycles, such as triple mutant cubes, constructed from the energies of the wild-type, three single mutants, three corresponding double mutants and the triple mutant (Horovitz and Fersht, 1990).”
BackgroundA structure‐based benchmark for protein–protein binding affinity
Kastritis, P. L., Moal, I. H., Hwang, H., Weng, Z., Bates, P. A., Bonvin, A. M. J. J., & Janin, J. (2011) · Protein Science · doi:10.1002/pro.580 · Cited by 313
Self-citationBarlow, K. A., Ó Conchúir, S., Thompson, S., Suresh, P., Lucas, J. E., Heinonen, M., & Kortemme, T. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b11367 · Cited by 295
Moal, I. H., & Fernández-Recio, J. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts489 · Cited by 281
Self-citationTwo-step binding mechanism for T-cell receptor recognition of peptide–MHC
Wu, L. C., Tuot, D. S., Lyons, D. S., Garcia, K. C., & Davis, M. M. (2002) · Nature · doi:10.1038/nature00920 · Cited by 280 · cited 1×
“[75]), binding pathways [61], and sequence-affinity landscapes [2].”
BackgroundA simple definition of structural regions in proteins and its use in analyzing interface evolution
Levy, E. D. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.09.028 · Cited by 254
Rational design of receptor-specific variants of human growth hormone.
Cunningham, B. C., & Wells, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3407 · Cited by 208
Molecular architecture of the human sperm IZUMO1 and egg JUNO fertilization complex
Aydin, H., Sultana, A., Li, S., Thavalingam, A., & Lee, J. E. (2016) · Nature · doi:10.1038/nature18595 · Cited by 184 · cited 1×
“Aydin,H. et al. (2016) Molecular architecture of the human sperm IZUMO1”
BackgroundAB ‐Bind: Antibody binding mutational database for computational affinity predictions
Sirin, S., Apgar, J. R., Bennett, E. M., & Keating, A. E. (2016) · Protein Science · doi:10.1002/pro.2829 · Cited by 179
Clark, L. A., Boriack‐Sjodin, P. A., Eldredge, J., Fitch, C., Friedman, B., Hanf, K. J. M., Jarpe, M., Liparoto, S. F., Li, Y., Lugovskoy, A., et al. (2006) · Protein Science · doi:10.1110/ps.052030506 · Cited by 173
On Human Disease-Causing Amino Acid Variants: Statistical Study of Sequence and Structural Patterns
Petukh, M., Kucukkal, T. G., & Alexov, E. (2015) · Human Mutation · doi:10.1002/humu.22770 · Cited by 165 · cited 1×
“SKEMPI has also been used to study human disease [56], [16], [55], assessing the role of dynamics on binding [69], exploring the conservation”
MethodA Mutational Analysis of Binding Interactions in an Antigen−Antibody Protein−Protein Complex
Dall'Acqua, W., Goldman, E. R., Lin, W., Teng, C., Tsuchiya, D., Li, H., Ysern, X., Braden, B. C., Li, Y., Smith-Gill, S. J., et al. (1998) · Biochemistry · doi:10.1021/bi980148j · Cited by 146
Hot spot-based design of small-molecule inhibitors for protein–protein interactions
Guo, W., Wisniewski, J. A., & Ji, H. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.095 · Cited by 142
Xiong, P., Zhang, C., Zheng, W., & Zhang, Y. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.11.022 · Cited by 140
Interaction Entropy for Computational Alanine Scanning
Yan, Y., Yang, M., Ji, C., & Zhang, J. Z. H. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00734 · Cited by 120
MutaBind estimates and interprets the effects of sequence variants on protein–protein interactions
Li, M., Simonetti, F. L., Goncearenco, A., & Panchenko, A. R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw374 · Cited by 118
The scoring of poses in protein-protein docking: current capabilities and future directions
Moal, I. H., Torchala, M., Bates, P. A., & Fernández-Recio, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-286 · Cited by 116 · cited 1×
“functions [48], [46] which were subsequently implemented in the CCharPPI web server for characterising protein-protein interactions [49], as well as being used for ranking docked poses [45], [58], [6], [50].”
MethodSelf-citationPetukh, M., Li, M., & Alexov, E. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004276 · Cited by 107
PINT: Protein-protein Interactions Thermodynamic Database
Kumar, M. D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj017 · Cited by 103
Moretti, R., Fleishman, S. J., Agius, R., Torchala, M., Bates, P. A., Kastritis, P. L., Rodrigues, J., Trellet, M. E., Bonvin, A. M. J. J., Cui, M., et al. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24356 · Cited by 100 · cited 1×
“Moretti,R. et al. (2013) Community-wide evaluation of methods for predicting the effect of mutations on protein-protein interactions.”
MethodSelf-citationLu, S. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031581398 · Cited by 99 · cited 1×
“, a systematic study of all possible mutations at selected sites in the turkey ovomucoid third domain and its inhibitory interactions with four proteases [43], as well as studies of interactions of the same domain in other bird”
BackgroundClark, A. J., Gindin, T., Zhang, B., Wang, L., Abel, R., Murret, C. S., Xu, F., Bao, A., Lu, N. J., Zhou, T., et al. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.11.021 · Cited by 96
A Detailed Thermodynamic Analysis of Ras/Effector Complex Interfaces
Kiel, C., Serrano, L. G., & Herrmann, C. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.050 · Cited by 95 · cited 1×
“Kiel,C. et al. (2004) A detailed thermodynamic analysis of ras/effector com-”
BackgroundBinding Hot Spots in the TEM1–BLIP Interface in Light of its Modular Architecture
Reichmann, D., Cohen, M., Abramovich, R., Dym, O., Lim, D., Strynadka, N. C. J., & Schreiber, G. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.09.076 · Cited by 92 · cited 2×
“Reichmann,D. et al. (2007) Binding hot spots in the TEM1-BLIP interface in light of its modular architecture. J. Mol. Biol., 365, 663–679. Roisman,L.C. et al. (2001) Structure of the interferon-receptor complex deter-”
BackgroundSeiradake, E., Lortat‐Jacob, H., Billet, O., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605316200 · Cited by 87
Characterization of the Functional Epitope on the Urokinase Receptor
Gårdsvoll, H., Gilquin, B., Du, M. L., Ménèz, A., Jørgensen, T. J. D., & Ploug, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513583200 · Cited by 84 · cited 2×
“Also notable is the alanine scanning of the urokinase-type plasminogen activator and its receptor from the group of Michael Ploug [21], studies of Ras effector interactions from the group of Christian Herrmann (e.”
BackgroundArkadash, V., Yosef, G., Shirian, J., Cohen, I., Horev, Y., Grossman, M., Sagi, I., Radisky, E. S., Shifman, J. M., & Papo, N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756718 · Cited by 83
CCharPPI web server: computational characterization of protein–protein interactions from structure
Moal, I. H., Jiménez‐García, B., & Fernández‐Recio, J. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu594 · Cited by 80
Self-citationRoisman, L. C., Piehler, J., Trosset, J.-Y., Scheraga, H. A., & Schreiber, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221290398 · Cited by 80
Berliner, N., Teyra, J., Çolak, R., Garcia Lopez, S., & Kim, P. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107353 · Cited by 79
Zhao, N., Han, J. G., Shyu, C.-R., & Korkin, D. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003592 · Cited by 78
PROXiMATE: a database of mutant protein–protein complex thermodynamics and kinetics
Jemimah, S., Yugandhar, K., & Michael Gromiha, M. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx312 · Cited by 75
Engineering a protein–protein interface using a computationally designed library
Guntas, G., Purbeck, C., & Kuhlman, B. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006528107 · Cited by 67 · cited 1×
“[24]), uncovering the effects of pathological mutations (e.”
BackgroundA Machine Learning Approach for Hot-Spot Detection at Protein-Protein Interfaces
Melo, R., Fieldhouse, R. J., Melo, A., Correia, J. D. G., Cordeiro, M. N. D. S., Gumus, Z. H., da Costa, J. P., Bonvin, A. M. J. J., & Moreira, I. S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081215 · Cited by 60 · cited 1×
“[30], [44], [42], [66]) and changes in binding energy (e.”
BackgroundPeng, Y., & Alexov, E. (2015) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24968 · Cited by 59 · cited 1×
“SKEMPI has also been used to study human disease (Petukh et al., 2015a; Das et al., 2014; Peng and Alexov, 2016), assessing”
MethodStructural interface between LRRK2 and 14-3-3 protein
Stevers, L. M., de Vries, R. M. J. M., Doveston, R. G., Milroy, L.-G., Brunsveld, L., & Ottmann, C. (2017) · Biochemical Journal · doi:10.1042/bcj20161078 · Cited by 59 · cited 1×
“[68]) and binding hotspots for drug design [25], altering binding kinetics [13], [64], protein-protein docking (e.”
BackgroundDourado, D. F. A. R., & Flores, S. C. (2014) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.24634 · Cited by 56
Nam, T., Jung, H. I., An, Y. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709295105 · Cited by 55 · cited 1×
“coli [52], in which the removal of the F136 side-chain of MlC creates a large cavity at the binding interface, the addition of a phenylalanine at the A451 position of IIBGlc”
BackgroundBroughton, S. E., Hercus, T. R., Nero, T. L., Dottore, M., McClure, B. J., Dhagat, U., Taing, H., Gorman, M. A., King-Scott, J., Lopez, A. F., et al. (2016) · Structure · doi:10.1016/j.str.2016.05.017 · Cited by 54
Simões, I. C. M., Costa, I. P. D., Coimbra, J. T. S., Ramos, M. J., & Fernandes, P. A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00378 · Cited by 52
The basis for limited specificity and MHC restriction in a T cell receptor interface
Piepenbrink, K. H., Blevins, S. J., Scott, D. R., & Baker, B. M. (2013) · Nature Communications · doi:10.1038/ncomms2948 · Cited by 49
Li, W., Dennis, C. A., Moore, G. R., James, R., & Kleanthous, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22253 · Cited by 44
Tidow, H., Veprintsev, D. B., Freund, S. M. V., & Fersht, A. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604725200 · Cited by 44 · cited 2×
“Tidow,H. et al. (2006) Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2). J. Biol. Chem., 281, 32526–32533. Vreven,T. et al. (2015) Updates to the integrated protein-protein interaction”
BackgroundA frustrated binding interface for intrinsically disordered proteins
Jemth, P., Mu, X., Engström, Å., & Dogan, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537068 · Cited by 42 · cited 1×
“Jemth,P. et al. (2014) A frustrated binding interface for intrinsically disordered”
BackgroundThe Iterative Protein Redesign and Optimization (IPRO) suite of programs
Pantazes, R. J., Grisewood, M. J., Li, T., Gifford, N. P., & Maranas, C. D. (2014) · Journal of Computational Chemistry · doi:10.1002/jcc.23796 · Cited by 41
Moal, I. H., & Fernández‐Recio, J. (2013) · Journal of Chemical Theory and Computation · doi:10.1021/ct400295z · Cited by 39 · cited 1×
“The first release has been used as a basis for many further studies, including the development of energy functions (Moal and Fernandez-Recio, 2013; Moal et al., 2015b) which were subsequently implemented in the CCharPPI web server for characterizing protein–protein interactions (Moal et al.”
MethodSelf-citationdbMPIKT: a database of kinetic and thermodynamic mutant protein interactions
Liu, Q., Chen, P., Wang, B., Zhang, J., & Li, J. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2493-7 · Cited by 38
Agius, R., Torchala, M., Moal, I. H., Fernández‐Recio, J., & Bates, P. A. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003216 · Cited by 37
Self-citationIRaPPA: information retrieval based integration of biophysical models for protein assembly selection
Moal, I. H., Barradas‐Bautista, D., Jiménez‐García, B., Torchala, M., van der Velde, A., Vreven, T., Weng, Z., Bates, P. A., & Fernández‐Recio, J. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx068 · Cited by 33
Self-citationLai, J. K. H., Ambía, J., Wang, Y., & Barth, P. (2017) · Structure · doi:10.1016/j.str.2017.09.002 · Cited by 33
Binding interface prediction by combining protein-protein docking results
Hwang, H., Vreven, T., & Weng, Z. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24354 · Cited by 32
Kulkarni, M. V., Tettamanzi, M. C., Murphy, J. W., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172072 · Cited by 31 · cited 1×
“Hodsdon [35], as well as studies into antigen recognition including the combined computational and experimental design study to enhance affinity of the AQC2 antibody to integrin α-1 from the group of Herman Van Vlijmen [12], the dissection of the interactions of broadly neutralising antibodies targeting HIV”
BackgroundDynamic use of multiple parameter sets in sequence alignment
Huang, X., & Brutlag, D. L. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1063 · Cited by 29 · cited 1×
“We determine the homology between proteins using the GAP4 program (Huang and Brutlag, 2007), and define homologous proteins as those with a similarity score greater than 50 and at least 30% sequence identity.”
MethodGeng, C., Vangone, A., & Bonvin, A. M. J. J. (2016) · Protein Engineering Design and Selection · doi:10.1093/protein/gzw020 · Cited by 28
Gossage, L., Pires, D. E. V., Olivera‐Nappa, Á., Asenjo, J. A., Bycroft, M., Blundell, T. L., & Eisen, T. G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu321 · Cited by 26
Das, J., Lee, H. R., Sagar, A., Fragoza, R., Liang, J. H., Wei, X., Wang, X., Mort, M. E., Stenson, P. D., Cooper, D. N., et al. (2014) · Human Mutation · doi:10.1002/humu.22534 · Cited by 24
Cohen-Khait, R., & Schreiber, G. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613122113 · Cited by 24
Pallara, C., Jiménez‐García, B., Pérez‐Cano, L., Romero‐Durana, M., Solernou, A., Grosdidier, S., Pons, C., Moal, I. H., & Fernández‐Recio, J. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24387 · Cited by 23
Self-citationEpa, V. C., Dolezal, O., Doughty, L., Xiao, X., Jöst, C., Plückthun, A., & Adams, T. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059163 · Cited by 23
Howitt, J. A., Bewley, M. C., Graziano, V., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301492200 · Cited by 23
Allosteric Dynamic Control of Binding
Sumbul, F., Acuner, S. E., & Haliloǧlu, T. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.08.011 · Cited by 22
Rosenfeld, R., Alcalay, R., Mechaly, A., Lapidoth, G. D., Epstein, E., Kronman, C., Fleishman, S. J., & Mazor, O. (2017) · Protein Engineering Design and Selection · doi:10.1093/protein/gzx028 · Cited by 19
Aizner, Y., Sharabi, O., Shirian, J., Dakwar, G. R., Risman, M., Avraham, O., & Shifman, J. M. (2014) · Structure · doi:10.1016/j.str.2014.01.012 · Cited by 18 · cited 1×
“Aizner,Y. et al. (2014) Mapping of the binding landscape for a picomolar”
BackgroundPfeiffenberger, E., Chaleil, R. A. G., Moal, I. H., & Bates, P. A. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25218 · Cited by 18
Self-citationBrown, N. G., Chow, D., Ruprecht, K. E., & Palzkill, T. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463521 · Cited by 14
Conservation of hot regions in protein–protein interaction in evolution
Hu, J., Li, J., Chen, N., & Zhang, X. (2016) · Methods · doi:10.1016/j.ymeth.2016.06.020 · Cited by 14
Inferring the microscopic surface energy of protein–protein interfaces from mutation data
Moal, I. H., Dapkūnas, J., & Fernández‐Recio, J. (2015) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24761 · Cited by 13
Self-citationCo-Occurring Atomic Contacts for the Characterization of Protein Binding Hot Spots
Liu, Q., Ren, J. F., Song, J., & Li, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144486 · Cited by 13
Barradas‐Bautista, D., Moal, I. H., & Fernández‐Recio, J. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25289 · Cited by 12 · cited 1×
“Barradas-Bautista,D. et al. (2017) A systematic analysis of scoring functions in”
BackgroundSelf-citationdbMPIKT: A web resource for the kinetic and thermodynamic database of mutant protein interactionsPreprint
Liu, Q., Chen, P., Wang, B., et al. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1708.01857 · Cited by 6 · cited 1×
“During data collection three other relevant databases were published: ABbind [67], PROXiMATE [31] and dbMPIKT [41].”
Method
Cited by
gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS
Valdés-Tresanco, M. S., Valdés-Tresanco, M. E., Valiente, P. A., & Moreno, E. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00645 · Cited by 3,393
Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
Chen, J., Wang, R., Gilby, N. B., & Wei, G.-W. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01451 · Cited by 653
Mutations Strengthened SARS-CoV-2 Infectivity
Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.07.009 · Cited by 466
“There are many standard databases available, including the AB-Bind database of mutation-induced antibody–antigen complex BFE changes [24] and SKEMPI for protein–protein BFE changes upon mutation (ΔΔG) [25,26].”
MethodLearning inverse folding from millions of predicted structures
Hsu, C., Verkuil, R., Liu, J., Lin, Z., Hie, B., Sercu, T., Lerer, A., & Rives, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.10.487779 · Cited by 416
“We evaluate models on zero-shot prediction of mutational effects on protein complex interfaces, using the Atom3D benchmark (Townshend et al., 2020) which incorporates binding free energy changes in the SKEMPI database (Jankauskait ˙ e et al., 2019) as a binary classification task.”
MethodmCSM-PPI2: predicting the effects of mutations on protein–protein interactions
Rodrigues, C. H. M., Myung, Y., Pires, D. E. V., & Ascher, D. B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz383 · Cited by 369
“…changes in thermodynamic and kinetic parameters on mutation for protein–protein complexes that have 3D structures deposited in the PDB. SKEMPI 2.0 (36) includes new mutations identified in the literature after its first release, including data available from three other databases: ABbind (37),…”
BackgroundInfluential
Metadata
- Authors
- Jankauskaitė, J., Jiménez-García, B., Dapkūnas, J., Fernández-Recio, J., & Moal, I. H.
- Affiliations
- Vilnius University (LT)
- Barcelona Supercomputing Center (BSC), Barcelona, Spain
- European Bioinformatics Institute (GB)
- Corresponding author
- Moal, Iain H
- Venue
- Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-07-18
- Volume
- 35
- Issue
- 3
- Pages
- 462-469
- ISSN
- 1367-4803 (ISSN-L)
- 1367-4811
- PMC
- PMC6361233
- OpenAlex
- W2953103783
- Cited by
- 389
- References
- 80
- Citations by year
- 2026: 63 · 2025: 75 · 2024: 61 · 2023: 50 · 2022: 46 · 2021: 37 · 2020: 33 · 2019: 18 · 2018: 5
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Bioinformatics (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (acceptedVersion, cc-by-nc-nd)
- UPCommons institutional repository (Universitat Politècnica de Catalunya) (acceptedVersion, cc-by-nc-nd)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- RIUR (Universidad de La Rioja) (submittedVersion, other-oa)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, cc-by-nc-nd)
- Funders
- European Molecular Biology Laboratory
- Biotechnology and Biological Sciences Research Council
- Future Leader Fellowship (BB/N011600/1)
- Spanish Ministry of Economy and Competitiveness
- MINECO (BIO2016-79930-R)
- Interreg POCTEFA (EFA086/15)
- European Commission (676566)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- protein-protein interaction, point mutations, binding kinetics, enthalpy and entropy changes, binding thermodynamics, sequence-structure-function relationships, protein engineering
- MeSH terms
- Kinetics, Mutation, Protein Binding, Thermodynamics, Databases, Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.